ASH 2025 – Neuigkeiten zur CLL
From Hämatologie Shortcasts by Dr. med. Richard Schabath, Dr. med. Andreas Hausmann, Dr. med. Stephan Fuhrmann
December 16, 2025 · 24 min · Season 4 · Episode 16
About this episode
Dr. Andreas Hausmann interviews Dr. Othman Al-Sawaf about the CLL17 study and its implications for CLL therapy.
People in this episode
Host: Dr. Andreas Hausmann
Guest: Dr. Othman Al-Sawaf
Topics covered
- CLL therapy
- ASH Meeting
- clinical trials
- treatment strategies
- patient outcomes
Keywords
- CLL
- BTK-Inhibition
- therapies
- TP53
- MRD
- Pirtobrutinib
- Richter-Transformation
Mentioned in this episode
Organizations: ASH, CLL17, CD20-Antikörpern, CLL18, CAR-T-Zellen
More episodes of Hämatologie Shortcasts
- Zwischen ASH und ASCO: Praxisrelevante Updates aus Lymphom, AML und Myelofibrose · June 11, 2026 · 18 min
- AML – Revolution oder Evolution? · February 27, 2026 · 26 min
- ASH 2025 - Aggressive B-Zell-Lymphome: Neue Optionen für ältere Patient:innen, Zelltherapien und Monitoring · February 5, 2026 · 18 min
- ASH 2025 – T-Zell-Lymphome: Neue Targets, frühe Rezidive und klinische Konsequenzen · January 19, 2026 · 29 min
- ASH 2025 – Epcoritamab & Co.: Wie sich die Therapie des follikulären Lymphoms verändert · December 19, 2025 · 20 min
- ASH 2025 - AML im Umbruch? · December 17, 2025 · 33 min
Explore listener stats, chart rankings, contacts and more on the Hämatologie Shortcasts podcast page.